tradingkey.logo
搜索

Revvity Inc

RVTY
添加自选
101.000USD
+2.150+2.17%
收盘 05/08, 16:00美东报价延迟15分钟
11.29B总市值
48.51市盈率 TTM

Revvity Inc

101.000
+2.150+2.17%
查看详细走势图
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.17%

5天

+16.52%

1月

+12.48%

6月

+9.45%

今年开始到现在

+4.39%

1年

+10.68%

TradingKey Revvity Inc股票评分

单位: USD 更新时间: 2026-05-08

操作建议

Revvity Inc当前公司基本面数据相对健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名11/206位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价111.79。中期看,股价处于平稳状态。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Revvity Inc评分

相关信息

行业排名
11 / 206
全市场排名
79 / 4494
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Revvity Inc亮点

亮点风险
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
高分红
公司属于高分红公司,最新股息支付率12.14%
稳定分红
公司5年内连续分红,最新股息支付率12.14%
估值合理
公司最新PE估值48.51,处于3年历史合理位
机构减仓
最新机构持股115.49M股,环比减少10.04%
钻石山资本公司持仓
明星投资者钻石山资本公司持仓,最新持仓市值430.06K

分析师目标

根据 19 位分析师
买入
评级
113.741
目标均价
+12.62%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Revvity Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Revvity Inc简介

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
公司代码RVTY
公司Revvity Inc
CEOSingh (Prahlad R)
网址https://www.revvity.com/
KeyAI